When partnering with Medial EarlySign, you are partnering with an organization relentlessly committed to the development of solutions and services designed to create strong personalized predictive models to assist in creation of new stratification and diagnostics tools, overcome gaps in data, and better identification methodologies for patients who would benefit from interventions. We partner with clients to bring forth solutions that identify and enrich subpopulations who could benefit from earlier treatment and to identify and prioritize patients when interventions stand more chance of halting or preventing the serious complications from the onset of disease.
We are in unprecedented times. From aging populations to a greater prevalence of chronic and infectious diseases, the demand for healthcare services is ever-rising. Coupled with health organizations gradually shifting focus from reactively treating patients to offering early intervention, the need for a proactive approach to early detection is stronger than ever. Healthcare organizations around the globe have adopted Medial EarlySign’s unique outcome-focused solutions, clinical AI frameworks, and AlgoMarkers to support their efforts in the potential for early detection of cancers, risk stratification of chronic and infectious disease complications, and predictions of unplanned readmissions and complications from infectious diseases. These high-performing models leverage multiple streams of clinical data like nothing else available today.
In collaboration with leading healthcare organizations, diagnostic companies, health systems, and research centers around the world, EarlySign partners to tackle today’s most complex healthcare challenges. We begin by reviewing and enhancing existing data assets, leveraging previously created models and customized versions, or designing new models that address the specific needs of our clients. In parallel, we work together to understand how the model insight fits into the workflow and with the goal of delivering outcome-focused solutions with clinical and economic value.
Discover opportunities for precise patient targeting, improved understanding in efficacy of treatment, optimize trial design, and more
Address complex conditions, monitor their progress, and proactively deliver timely care management insights
Impact the health of populations by identifying at-risk individuals for whom early detection and intervention may have a significant impact
Enhance raw lab test results with clinical and actionable prediction models. Provide improved performance and care-level value to caregivers and patients.
We help healthcare organizations manage risk associated with new and innovative projects with proven data science and a guided approach to simplify the complex and insurmountable amounts of data available. Our expert staff of researchers, physicians, data scientists, healthcare IT executives, and developers work together with you to solve real healthcare challenges with applied data science.
Our capabilities enable us to collaborate across the healthcare ecosystem, working with multiple stakeholders who wish to harness clinical signals to derive patient-level insights. Whether we leverage existing solutions or custom build predictive models, our quality solutions have led us to be recognized as a valued partner.
Through rich technology, proven expertise, and real results, our team delivers tangible value to patients and healthcare stakeholders across the continuum. With the timely delivery of customized clinical insights driven from real-world clinical data and validated as described in peer-reviewed publications, EarlySign clients have proven success in clinical practice.
